187 related articles for article (PubMed ID: 38274883)
1. A case report of acute intermittent porphyria leading to severe disability.
Lin J; Liu J; Wang A; Si Z
Front Neurol; 2023; 14():1334743. PubMed ID: 38274883
[TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Wang B; Bonkovsky HL; Lim JK; Balwani M
Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
[TBL] [Abstract][Full Text] [Related]
3. Acute Intermittent Porphyria: Complete Phenotype in a Patient with p.Arg173Trp Variant in Thailand.
Sriprakoon V; Ittagornpunth C; Puapaiboon N; Bunyahathaipat A; Piriyanon P; Khositseth S; Rojnueangnit K
Am J Case Rep; 2022 Nov; 23():e937695. PubMed ID: 36329616
[TBL] [Abstract][Full Text] [Related]
4. Acute intermittent porphyria: a test of clinical acumen.
Dhital R; Basnet S; Poudel DR; Bhusal KR
J Community Hosp Intern Med Perspect; 2017 Mar; 7(2):100-102. PubMed ID: 28638573
[TBL] [Abstract][Full Text] [Related]
5. The diagnosis of acute intermittent porphyria combined with seizures: Case report.
Wang Z; Cheng L; Liang X; Jiang H; Shen R
Medicine (Baltimore); 2023 Dec; 102(50):e36167. PubMed ID: 38115298
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
Prabahar MR; Manorajan R; Sathiyakumar D; Soundararajan P; Jayakumar M
Hemodial Int; 2008 Jan; 12(1):34-8. PubMed ID: 18271838
[TBL] [Abstract][Full Text] [Related]
7. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
Sardh E; Harper P; Andersson DE; Floderus Y
Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
[TBL] [Abstract][Full Text] [Related]
8. Novel Mutation of Hydroxymethylbilane Synthase in a Case of Acute Intermittent Porphyria Presenting with Posterior Reversible Encephalopathy Syndrome.
Yang AL; Ma LM; Zhang HJ; Zhang JW
J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS102-SS104. PubMed ID: 36597305
[TBL] [Abstract][Full Text] [Related]
9. Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse.
Unzu C; Sampedro A; Sardh E; Mauleón I; Enríquez de Salamanca R; Prieto J; Salido E; Harper P; Fontanellas A
PLoS One; 2012; 7(3):e32978. PubMed ID: 22412963
[TBL] [Abstract][Full Text] [Related]
10. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families.
Kauppinen R; von und zu Fraunberg M
Clin Chem; 2002 Nov; 48(11):1891-900. PubMed ID: 12406973
[TBL] [Abstract][Full Text] [Related]
11. A case of acute intermittent porphyria.
Ahmed M; Ahmed MS; Patwary MI; Miah MT; Hasan MK; Hossain SZ; Sultana B; Chakraborty SR
Mymensingh Med J; 2015 Apr; 24(2):420-3. PubMed ID: 26007278
[TBL] [Abstract][Full Text] [Related]
12. Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs.
Ruspini SF; Zuccoli JR; Lavandera JV; Martínez MDC; Oliveri LM; Gerez EN; Batlle AMDC; Buzaleh AM
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1296-1305. PubMed ID: 29476795
[TBL] [Abstract][Full Text] [Related]
13. Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria.
Aarsand AK; Petersen PH; Sandberg S
Clin Chem; 2006 Apr; 52(4):650-6. PubMed ID: 16595824
[TBL] [Abstract][Full Text] [Related]
14. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.
Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N
Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865
[TBL] [Abstract][Full Text] [Related]
15. Acute Intermittent Porphyria Presenting with Posterior Reversible Encephalopathy Syndrome: A Rare Cause of Abdominal Pain and Seizures.
Sarala Kumari D; Arumilli MN; Siva Kumar Reddy L; Reddy DN; Motor R
Indian J Crit Care Med; 2020 Aug; 24(8):724-726. PubMed ID: 33024385
[TBL] [Abstract][Full Text] [Related]
16. Acute intermittent porphyria: focus on possible mechanisms of acute and chronic manifestations.
Ma Y; Teng Q; Zhang Y; Zhang S
Intractable Rare Dis Res; 2020 Nov; 9(4):187-195. PubMed ID: 33139977
[TBL] [Abstract][Full Text] [Related]
17. Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model.
Vera-Yunca D; Serrano-Mendioroz I; Sampedro A; Jericó D; Trocóniz IF; Fontanellas A; Parra-Guillén ZP
Mol Genet Metab; 2019 Nov; 128(3):367-375. PubMed ID: 30639045
[TBL] [Abstract][Full Text] [Related]
18. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion.
Floderus Y; Sardh E; Möller C; Andersson C; Rejkjaer L; Andersson DE; Harper P
Clin Chem; 2006 Apr; 52(4):701-7. PubMed ID: 16497943
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
